about
Evolution of animal models in cancer vaccine developmentCryotherapy with concurrent CpG oligonucleotide treatment controls local tumor recurrence and modulates HER2/neu immunity.In situ immunization via non-surgical ablation to prevent local and distant tumor recurrence.Differential CTLA-4 expression in human CD4+ versus CD8+ T cells is associated with increased NFAT1 and inhibition of CD4+ proliferation.Immunotherapeutic intervention with oncolytic adenovirus in mouse mammary tumors.Induction of HER2 Immunity in Outbred Domestic Cats by DNA Electrovaccination.Induction of proapoptotic antibodies to triple-negative breast cancer by vaccination with TRAIL death receptor DR5 DNA.Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome.Layer-by-layer films with bioreducible and nonbioreducible polycations for sequential DNA release.Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides -- cutaneous T cell lymphoma.The importance of examining an active immune system during immunotherapyIFNγ PET Imaging as a Predictive Tool for Monitoring Response to Tumor ImmunotherapyAn HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic mice
P50
Q28080739-2FEAEA7C-743C-4886-8CEB-C2590E41FB82Q34288183-852A2FFD-9076-4CCA-8F05-49A200447C04Q34475389-197D6146-4AB9-4044-B163-418064D731E9Q34824109-71E9349D-BF58-4FB7-83E2-F6B94536D85DQ35201826-52AE021E-08E1-44F9-A714-AD0F5325C86AQ35815995-084D91D1-9441-4131-9949-BB7D4A3D7EBFQ36070101-5F1A94F0-4D37-43B7-97F3-751E08483385Q38895486-42680B2B-1296-412C-9115-2F739728E99EQ46819419-AF5730BE-478A-49E8-A6B3-AABE209DF56DQ52997711-B38A84EB-3709-4E8D-8C92-E079B242E501Q61817215-28D6C827-67DB-4FAC-8803-858D8C73217CQ90987258-591B14A9-B403-4F5D-A7F4-AFAE99A5F1EEQ92608967-B9EA42DA-8F3A-4739-8750-167CC033D257
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Heather M Gibson
@en
Heather M Gibson
@nl
type
label
Heather M Gibson
@en
Heather M Gibson
@nl
prefLabel
Heather M Gibson
@en
Heather M Gibson
@nl
P31
P496
0000-0003-2652-8252